Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice

Background: Alpha-synuclein, abnormally aggregated in Dementia with Lewy Bodies (DLB), could represent a potential biomarker to improve the differentiation between DLB and Alzheimer’s disease (AD). Our main objective was to compare Cerebrospinal Fluid (CSF) alpha-synuclein levels between patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lilamand, Matthieu, Clery, Josué, Vrillon, Agathe, Mouton-Liger, François, Cognat, Emmanuel, Gaubert, Sinead, Hourregue, Claire, Martinet, Matthieu, Dumurgier, Julien, Hugon, Jacques, Bouaziz-Amar, Elodie, Paquet, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654229/
https://www.ncbi.nlm.nih.gov/pubmed/36362275
http://dx.doi.org/10.3390/ijms232113488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654229/
https://www.ncbi.nlm.nih.gov/pubmed/36362275
http://dx.doi.org/10.3390/ijms232113488

Ejemplares similares